Guide for patients & caregivers

What Does ER Positive Mean on a Breast Pathology Report?

ER positive and PR positive on a breast pathology report: what hormone receptor results, percentages and Allred scores mean, and how they guide treatment.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does ER positive mean on a breast pathology report?

ER positive (ER+) means the breast cancer cells have oestrogen receptors: proteins that let the hormone oestrogen attach to the cells and help them grow. PR positive (PR+) means the cells have progesterone receptors. A cancer with either or both is called hormone receptor positive (HR+), and it is usually offered hormone therapy.

US reports spell it estrogen. The American Cancer Society says about 3 in 4 breast cancers have at least one of these receptors, and Breast Cancer Now says most breast cancers are ER positive. All invasive breast cancers should be tested for both receptors, on the biopsy sample or on tissue removed at surgery.

This guide explains the wording on the report. It cannot tell you your diagnosis, stage or which treatment is right for you.

Symptoms that need urgent care during treatment

A hormone receptor result is not an emergency in itself. If you have started chemotherapy or another cancer treatment, the NHS advises calling your care team straight away if you have:

  • a high temperature, or feeling hot, cold, sweaty or shivery
  • other signs of infection, such as a sore throat, cough, diarrhoea or pain when peeing
  • throbbing or cramping pain, swelling and warmth in an arm or leg
  • sudden breathlessness, sharp chest pain, or coughing up blood

How are hormone receptors tested?

Labs usually use immunohistochemistry (IHC). Lab-made antibodies that stick only to the oestrogen or progesterone receptor are added to a slice of the tissue, and a stain makes positive cell nuclei visible under the microscope. ER and PR are tested and reported separately.

The NHS notes that biopsy results, including these protein tests, can take 1 to 2 weeks. Ductal carcinoma in situ (DCIS) should also be checked for hormone receptors, according to the American Cancer Society.

How to read ER percentages and staining strength

The American Cancer Society explains that results may be written as negative, weakly positive or positive; as a percentage of positive cells; or as a percentage plus whether staining is weak, moderate or strong. It describes these bands:

  • Negative: fewer than 1% of cancer cells stain.
  • Low positive: 1% to 10% of cells stain.
  • Positive: more than 10% of cells stain.

What is an Allred score?

Some labs add an Allred score (sometimes called a Quick score). It combines two numbers: a proportion score from 0 to 5 for how many cells stain, and an intensity score from 0 to 3 for how strongly they stain. Added together, they give a total of 0 or 2 to 8.

In the Allred system, the International Collaboration on Cancer Reporting (ICCR) dataset states that totals of 0 and 2 are considered negative and 3 to 8 positive. With sensitive modern staining, most cancers fall clearly into a high score (7 or 8) or a score of 0, and only a small group sits in between.

The same dataset says the percentage of stained cells takes priority: any cancer with 1% or more positive cells should be called receptor positive, and fewer than 1% negative, whatever the Allred score. So if the percentage and the score seem to disagree, ask your team which result they are using.

A higher score shows more receptor staining. It is not a stage, a grade or a prediction for an individual person.

What if my cancer is ER positive but PR negative, or only PR positive?

Breast Cancer Now explains that most PR-positive cancers are also ER positive, and that hormone therapy is usually offered when a cancer is both. Cancers that are only PR positive are uncommon, and the benefit of hormone therapy is less clear, so the team discusses whether it is suitable.

The ICCR dataset notes that a true ER-negative, PR-positive result is extremely rare, and that labs may recheck the staining when they see it. If neither receptor is present, the cancer is hormone receptor negative and hormone therapy will not help.

How does hormone receptor status affect treatment?

Treatment depends on the whole picture: the type and size of the cancer, grade, lymph nodes, HER2 status, whether it has spread, menopausal status and your general health. In general terms, hormone therapy works by lowering the amount of oestrogen in the body or blocking it from reaching the cancer cells.

The National Cancer Institute describes hormone therapy being used after surgery to lower the chance of the cancer coming back, before surgery to shrink a tumour in some cases, and for cancer that has come back or spread. The NCI explains that the type chosen often depends on whether you have gone through the menopause. Surgery, radiotherapy, chemotherapy or targeted medicines may also be part of the plan.

If the cancer is also HER2 positive (sometimes called triple positive), HER2-targeted medicines may be added. Do not stop or change a prescribed hormone therapy without talking to your prescriber; the NCI notes that side effects can often be managed by changing the approach.

Questions to ask your breast cancer team

Bringing the report and a written list can help:

  • What were my ER and PR percentages, and was an Allred score given?
  • Is my result clearly positive, low positive or negative?
  • How do my ER, PR and HER2 results fit together?
  • Is hormone therapy recommended for me, and would it come before or after surgery?
  • What side effects are common, and what should I report?
  • Which other tests, if any, are still being done on the sample?

How comparing similar cases on SameCase can help

On SameCase, patients and verified doctors share de-identified cases. Reading how others with similar ER and PR results described their reports and treatment discussions can help you prepare clearer questions.

Other people's cases cannot tell you what your result means or which treatment will suit you. Use them to plan your questions, then go through those questions with the team that knows your full results.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning